Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial

• मुख्य लेखकों: Peter C Rockers, ScD (लेखक), Richard O Laing, ProfMD (लेखक), Paul G Ashigbie, DrPH (लेखक), Monica A Onyango, PhD (लेखक), Carol K Mukiira, MA (लेखक), Veronika J Wirtz, PhD (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2019-04-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Summary: Background: Novartis Access is a Novartis programme that offers a portfolio of non-communicable disease medicines at a wholesale price of US$1 per treatment per month in low-income and middle-income countries. We evaluated the effect of Novartis Access in Kenya, the first country to receive...